BIOSYNEX SA: Declaration of Shares and Voting Rights

BIOSYNEX SA published on November 4, 2024 a regulatory update concerning the number of shares making up its share capital as well as the total voting rights. As of October 31, 2024, the company's capital consists of 10,760,870 shares. In addition, the total number of net voting rights amounts to 14,544,074.

This communication is part of the regulatory obligations provided for by Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulations of the Financial Markets Authority. BIOSYNEX, specializing in rapid health diagnostic solutions, continues to strengthen its market position by complying with financial transparency guidelines.